57 related articles for article (PubMed ID: 34870139)
1. N-Acetyl cysteine amide and cerium oxide nanoparticles as a drug delivery for ischemic stroke treatment: Inflammation and oxidative stress crosstalk.
Fayyazi F; Ebrahimi V; Mamaghani MM; Abgharmi BA; Zarrini G; Mosarrezaii A; Charkhian H; Gholinejad Z
J Trace Elem Med Biol; 2023 Dec; 80():127300. PubMed ID: 37741051
[TBL] [Abstract][Full Text] [Related]
2. The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More than Redox?
Corsi F; Deidda Tarquini G; Urbani M; Bejarano I; Traversa E; Ghibelli L
Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887953
[TBL] [Abstract][Full Text] [Related]
3. Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles.
Aghara H; Chadha P; Zala D; Mandal P
Front Immunol; 2023; 14():1205821. PubMed ID: 37841267
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances.
Nasiri-Ansari N; Kassi E
Metabol Open; 2023 Mar; 17():100229. PubMed ID: 36686606
[No Abstract] [Full Text] [Related]
5. Intranasal Cerium Oxide Nanoparticles Ameliorate Cognitive Function in Rats with Alzheimer's via Anti-Oxidative Pathway.
Danish SM; Gupta A; Khan UA; Hasan N; Ahmad FJ; Warsi MH; Ali AMA; Zafar A; Jain GK
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456590
[TBL] [Abstract][Full Text] [Related]
6. The use of cerium oxide nanoparticles in liver disorders: A double-sided coin?
Attia N; Rostom DM; Mashal M
Basic Clin Pharmacol Toxicol; 2022 Mar; 130(3):349-363. PubMed ID: 34902883
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Cerium Oxide Nanoparticles in Non-Alcoholic Fatty Liver Disease Evolution Using In Vivo and In Vitro Studies: A Systematic Review.
Sandoval C; Reyes C; Rosas P; Godoy K; Souza-Mello V; FarÃas J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958712
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver.
Abbasi E; Vafaei SA; Naseri N; Darini A; Azandaryani MT; Ara FK; Mirzaei F
Metabol Open; 2021 Dec; 12():100151. PubMed ID: 34870139
[TBL] [Abstract][Full Text] [Related]
9. Multi-organ Toxicity Attenuation by Cerium Oxide and Yttrium Oxide Nanoparticles: Comparing the Beneficial Effects on Tissues Oxidative Damage Induced by Sub-acute Exposure to Diazinon.
Navaei-Nigjeh M; Daniali M; Rahimifard M; Khaksar MR
Pharm Nanotechnol; 2020; 8(3):225-238. PubMed ID: 32767961
[TBL] [Abstract][Full Text] [Related]
10. Aortic Oxidative Stress, Inflammation and DNA Damage Following Pulmonary Exposure to Cerium Oxide Nanoparticles in a Rat Model of Vascular Injury.
Nemmar A; Al-Salam S; Beegam S; Yuvaraju P; Ali BH
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426470
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of chrysin against carbon tetrachloride-induced kidney and liver tissue damage in rats.
Baykalir BG; Arslan AS; Mutlu SI; Parlak Ak T; Seven I; Seven PT; Yaman M; Gul HF
Int J Vitam Nutr Res; 2021 Sep; 91(5-6):427-438. PubMed ID: 32349632
[No Abstract] [Full Text] [Related]
12. Jiang-Zhi granules decrease sensitivity to low-dose CCl
Yang L; Zhou Y; Song H; Zheng P
BMC Complement Altern Med; 2019 Aug; 19(1):228. PubMed ID: 31438932
[TBL] [Abstract][Full Text] [Related]
13. Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Lebda FM; El Agaty SM; Ali RH; Galal Hamam G; Abd El-Monem AM; Lasheen NN
Gen Physiol Biophys; 2022 Sep; 41(5):431-446. PubMed ID: 36222341
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
